1-7 of 7
Yumi Nakayama
Close
Sort by
Journal Articles

Pharmacodynamic Biomarkers and CtDNA Support the Mechanism of Action and Clinical Efficacy of Golcadomide (CC-99282) Combined with R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma

Mark Kaplan, Tara Basavanhally, Yumi Nakayama, Charalampos Kyriakopoulos, Arnaud Amzallag, Argyrios Gkasiamis, Arpankumar Patel, Akshay Sudhindra, Grzegorz S. Nowakowski, Jason Westin, Anita K. Gandhi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1631.
https://doi.org/10.1182/blood-2023-180231
Published: 2023
Journal Articles

Emergence of Highly-Plastic B Cell States Cooperates with Early Immune Microenvironment Remodeling to Drive Follicular Lymphomagenesis

Gabriel Brisou, Sabrina Baaklini, Noushin Mossadegh-Keller, Alicia Beyou, Manon Zala, Laurine Gil, Camille Soun, Caroline Huber, Iñaki Cervera-Marzal, Agnés Bru, Delphine Potier, Stéphanie Gon, Lionel Chasson, Asier Antoranz, Jon Pey Perez, Anita K. Gandhi, Yumi Nakayama, Patrick R Hagner, Pierre Milpied, Bertrand Nadel, Sandrine Roulland
Journal: Blood
Blood (2023) 142 (Supplement 1): 717.
https://doi.org/10.1182/blood-2023-185829
Published: 2023
Journal Articles

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Matthew E Stokes, Kerstin Wenzl, C. Chris Huang, Maria Ortiz Estevez, Matthew J. Maurer, Nicholas Stong, Patrick Hagner, Yumi Nakayama, Chih-Chao Hsu, Samuel A Danziger, Fadi Towfic, Rebecca L. King, Joel S. Parker, Brian K. Link, Susan L. Slager, Vivekananda Sarangi, Yan Asmann, Joseph P. Novak, Akshay Sudhindra, Stephen M. Ansell, Thomas M. Habermann, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak, Anita K. Gandhi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3548–3550.
https://doi.org/10.1182/blood-2022-170228
Published: 2022
Journal Articles

High-Plex Imaging and Cellular Neighborhood Spatial Analysis Reveals Multiple Immune Escape and Suppression Patterns in DLBCL

David J. Reiss, C. Chris Huang, Yumi Nakayama, Matthew E. Stokes, Andrew P. Weng, Anita K. Gandhi
Journal: Blood
Blood (2022) 140 (Supplement 1): 166–167.
https://doi.org/10.1182/blood-2022-162789
Published: 2022
Journal Articles

Differential Effects of Iberdomide Versus Revlimid on Leukocyte Trafficking, Immune Activation and DLBCL Tumor Cell Killing

Yumi Nakayama, Hsiling Chiu, Rama K. Narla, Arvind Shakya, Jim Gamez, Isobelle Wall, Despoina Papazoglou, Benedetta Apollonio, Alan G. Ramsay, Patrick Hagner, Anita K Gandhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 718.
https://doi.org/10.1182/blood-2021-153063
Published: 2021
Journal Articles

Profiling the Immune Tumor Microenvironment of Newly Diagnosed Diffuse Large B Cell Lymphoma Identifies Three Major Immune Infiltration Patterns

C. Chris Huang, PhD, Yumi Nakayama, PhD, Matthew Stokes, PhD, Fadi Towfic, PhD, chung-Wein Lee, Yan Ren, Mathieu Marella, PhD, Maria Wang, Patrick R. Hagner, PhD, Suzana Couto, Kathryn Newhall, Anita K Gandhi
Journal: Blood
Blood (2019) 134 (Supplement_1): 2797.
https://doi.org/10.1182/blood-2019-123691
Published: 2019
Journal Articles

Mechanism of Synergistic Effects on T Cell Activation By Avadomide (CC-122) and Nivolumab

Yumi Nakayama, PhD, Matthew E. Stokes, PhD, Michelle Waldman, MS, Patrick R. Hagner, PhD, Anita K. Gandhi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4133.
https://doi.org/10.1182/blood-2018-99-114469
Published: 2018